Innovations in Neuromodulation
Neuromodulation: Bridging Minds, Machines, and Medicine, our seventh Innovations Day educational event for the neuromodulation innovation and investment community, will take place on Sunday 10th May in Lisbon, Portugal, as part of the official pre-conference of the INS 17th World Congress. This unique event will bring together leaders in the global neuromodulation and investment communities to share the wealth of their experiences, and their visions for the future of this exciting and rapidly evolving field.
In this Innovations Day, INS is presenting an opportunity for innovators to share their company stories with venture capitalists, clinicians, engineers and other Industry members. To fit in with the Congress’s theme, we are asking participating companies to highlight their innovation process and how they have bridged the neuroprosthesis interface. For example, the unique way that a therapy is developed and delivered to solve a particular problem or need and the barriers that need to be overcome. The day will include multiple panels and talks, with participants to get platform time either individually or as a part of panel discussion.
In addition to the presenters, we will have senior Venture Capital investors from a number of major companies in attendance. This will be an excellent opportunity for you and your company to showcase your achievements, create new contacts, learn from your peers, gauge your progress and, as a result, become more competitive and successful!
We have developed the 2026 program with an aim of achieving several objectives:
- Truly understand the power of future AI and how it will revolutionize what and how do things.
- Learn different approaches to teaching and learning the art and the business of entrepreneurship.
- Understand the ethical and socio-economic implications in innovating in the neuromodulation space.
- Learn about the power of media and messaging in the innovation space.
- Find out about current and future investment strategies and challenges in the device market from across the globe.
- Discover emerging companies and the science behind their innovative therapies.
- Network with the leaders in innovation, investment, basic science and clinical practice in the neuromodulation space.
VIEW THE PRELIMINARY PROGRAM HERE
Questions & Contact
Please feel free to contact the International Neuromodulation Society with any questions regarding participation in the Innovations Day pre-conference or exhibiting at the main congress.
We look forward to welcoming you to Lisbon.
Dr. Marc Russo
Co-Chair, Innovations in Neuromodulation
Dr. Philippe Rigoard
Co-Chair, Innovations in Neuromodulation
Mr. Jim Cavuoto
Co-Chair, Innovations in Neuromodulation
We encourage you to consider participating in our emerging company panels and, if you are interested, submit your application* to join a panel at your earliest convenience.
* Each company selected to participate in the emerging company panels will be kindly requested to provide a $2,500 US unrestricted grant to the International Neuromodulation Society, a 501(c)3 nonprofit organization.
Previous Participating Companies
Vancouver – 2024
Abbott
Aurimod
Boston
Flagler Health
Mainstay
Medtronic
Neuromod Devices
Nevro
ReBrain
Saluda
Spark Biomedical
Barcelona – 2022
Abbott
Bios Health
Boston
Mainstay
Medtronic
Neuroelectrics
Neuromod Devices Limited
Nevro
NXTSTIM
RebrAIn
Saluda
Spark Biomedical
Stimwave
Synergia Medical SA
Thermaquil, Inc.apeutics
WISE Srl
Sydney – 2019
Abbott
Beijing Aldans Biotech Co., Ltd.
Boston Scientific
Cala Health
GTX Medical
Mainstay Medical
Medtronic
Nalu Medical
Nuvectra
Saluda Medical
Stimrelieve
Stimwave
Synergia Medical
Thermaquil
Edinburgh – 2017
Bioinduction Ltd
BlueWind Medical
Clearly Present Foundation
G-Therapeutics
GiMer Medical
Helius Medical Technologies
Mainstay Medical
MicroTransponder
NeuroNano
Ripple
Theranica Bio-Electronics Ltd.
WISE Srl
Wyss Center for Bio & Neuroengineering
Montreal – 2015
Axonics Modulation Technologies
BlueWind Medical
CorTec
FemPulse LLC
Lungpacer Medical Inc.
Medtronic Eindhoven Design Center, formerly Sapiens Steering Brain Stimulation
MicroTransponder
Neuronano AB
Neuros Medical
SPR Therapeutics
WISE Srl
Berlin – 2013
Aleva Neurotherapeutics
Algostim
Biotectix
Endostim
Functional Neuromodulation
Mainstay Medical
NeuroNexus
Neuros Medical
NeuroSigma
Neurotargeting
Nexstim Oy
Sapiens Steering Brain Stimulation
Stimwave Technologies
WISE Srl
London – 2011
Autonomic Technologies
Cerebral Rx
Functional Neuromodulation
ImThera Medical
NDI Medical
Neuros Medical
Nevro Corp.
QiG Group / Algostim
Spinal Modulation
Through our theme of ‘From Scientific Possibility to Viable Company – How to Make the Journey’, we are presenting a series of plenary talks that will explore the journey of:
-
01.
Creating a concept
-
02.
Formulating a company
-
03.
Executing a business plan
-
04.
Integrating entry into the market
We will be looking at different aspects of this in the neuromodulation world from AI to batteries to nanotech and much more. In addition watch out for our special closing plenary which promises to be a very stimulating and eye-opening presentation!
The 2024 program has been crafted with several key objectives in mind
- Identify and discuss essential data collection by commercializing companies to ensure its relevance for future approval and reimbursement applications.
- Understand the entire lifecycle of innovations, from inception to funding, approval, reimbursement, and market entry.
- Explore the intricacies of establishing and safeguarding intellectual property.
- Learn about available public scientific initiatives for potential partnerships.
- Gain insights into current and future investment strategies and challenges in the device market across different continents.
- Discover emerging companies and the scientific foundations of their innovative therapies.
- Network with leaders in innovation, investment, basic science, and clinical practice within the neuromodulation space.
Saturday, 11 May 2024 – East Ballroom AB, Vancouver Convention Centre (East Building)
Moderators: Marc Russo, Philippe Rigoard, James Cavuoto and Ashish Gulve
08:30 – 09:00 Breakfast
09:00 – 09:10 Welcome and Introduction to the Themes of the Day
09:10 – 09:35 Lecture 1: You are a Physician, You Have an Idea – Where to Next? Dr. Andrew Sullivan – Presidio Medical
09:35 – 09:55 Trends in the Industry: A Perspective from Neurotech Reports James Cavuoto
09:55 – 10:45 Emerging Company Panel – I Discussion
10:45 – 11:10 Lecture 2: Startups in a Funding Winter – How to Survive and Thrive Doug Evans, Lungpacer Medical
11:10 – 11:40 Networking Break
11:40 – 12:30 Emerging Company Panel – II Discussion
12:30 – 12:55 Lecture 3: Nanotechnology – Is it Going Anywhere? Bianxiao Cui
12:55 – 13:55 Lunch
13:55 – 14:45 Emerging Company Panel – III Discussion
14:45 – 15:10 Lecture 4: Next Gen Batteries for Neuromodulation – What Will They Look Like? Gregg Bruce, Resonetics
15:10 – 15:35 Lecture 5: Are Neuromod Apps Useful or a Tech Version of NFTs? Erika Ross Ellison, ONWARD
15:35 – 16:05 Networking Break
16:05 – 16:30 Lecture 6: Do We Need to Understand Mechanisms to Invent the Next Breakthrough? Marom Bikson
16:30 – 16:55 Lecture 7: What do Third Party Payers Want from Startups? Katherine Neuenfeldt, Presidio Medical
16:55 – 17:25 Lecture 8: Closing Address- Should We be Teaching our Children to Neuromodulate their Own Brains Marc Russo
17:25 – 17:45 Closing Remarks
We encourage you to consider participating in our emerging company panels and, if you are interested, submit your application to join a panel at your earliest convenience. For your reference, a list of previous participating companies and investors is posted below.
* Each company selected to participate in the emerging company panels will be kindly requested to provide a $2,500 US unrestricted grant to the International Neuromodulation Society, a 501(c)3 nonprofit organization.
Previous Participating Companies
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.